Pharmaceutical companies have invested more than EUR 800 million in Serbia
According to Provincial Secretary for Interregional Cooperation and Local Self-Government Branislav Bugarski, development strategy for pharmaceutical sector has to be created on a state, as well as a local level. Good example is the municipality of Vrsac which has developed Industrial-Technology Park, and immediately after Stada, attracted other foreign investments, such as "Fresenius medical care ", "Lamp east", "Ave Pharmaceutical".
- Center of pharmaceutical industry is in Banat, actually in Vrsac and Zrenjanin, and according to our experience, investors go where tradition of certain production exists. It is highly important for Vrsac to continue development of its Industrial Technology Park, invest in scientific research and develop business incubator. Zrenjanin needs to help Jugoremedija develop – said Bugarski.
As Vladan Atanasijevic a president of NALED Managing Board said, towns and municipalities will have significantly more success if they target investments for economy branch which has the largest number of available resources and to offer friendly business environment.
- Investors expect fast procedures from local administration, a fair treatment and a predictable environment. Local self-governments could reach those standards through NALED’s certification program for municipalities with friendly business environment. This program clearly shows how to improve administration and make an environment attractive for investments. Quality of the program is proved by the fact that our neighbours, Croatia, Macedonia and Bosnia and Herzegovina, have decided to join it and certify their local self-governments – said Atanasijevic.
As a consultant of NALED and a health expert Simo Vukovic specified, it is important to attract new investments in pharmaceutical industry, as one of five main sectors in EU, believed to be the key for future development of European and world economy.
- Serbian pharmaceutical industry is not well developed and rarely participates in gross domestic product. When it comes to export, this industry does not belong into first ten sectors, while it has the fifth place in the import sector, which is proved by the fact that we spend EUR 600 million for foreign medicines annually. Our chance is in generic drugs production, due to their 20% lower price – said Vukovic.
Representatives of local self-governments and economy have heard also different experience of investors in Vrsac. Vojislav Bugarski, a production manager in "Fresenius Medical Care Serbia" said the factory will be built in this municipality due to friendly environment for investment and qualified workers.
CEO of "Ave Pharmaceutical" Aleksandar Brankov reported his positive experience in investments here and pointed out certain problems with republic administration, giving an example that the factory has been built in nine months while it took them fifteen months to complete red tape procedures. Ljubisa Milosavljevic, a CEO of "Lamp East" advised municipalities to be transparent and obey agreements with investors.